136 related articles for article (PubMed ID: 31567874)
1. What information do healthcare professionals need to inform premenopausal women about risk-reducing salpingo-oophorectomy?
Hickey M; Rio I; Trainer A; Marino JL; Wrede CD; Peate M
Menopause; 2020 Jan; 27(1):20-25. PubMed ID: 31567874
[TBL] [Abstract][Full Text] [Related]
2. Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women.
Hickey M; Rio I; Trainer A; Marino JL; Wrede CD; Peate M
Menopause; 2020 Jan; 27(1):26-32. PubMed ID: 31613831
[TBL] [Abstract][Full Text] [Related]
3. What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.
Hickey M; Trainer A; Braat S; Davey MA; Krejany E; Wark J
BMJ Open; 2017 Nov; 7(11):e018758. PubMed ID: 29138210
[TBL] [Abstract][Full Text] [Related]
4. Risk-reducing salpingo-oophorectomy among diverse patients with
Lamacki AJ; Spychalska S; Maga T; Balay L; Lugo Santiago N; Hoskins K; Richardson K; Class QA; MacLaughlan David S
BMJ Open; 2024 Jun; 14(6):e082608. PubMed ID: 38889943
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy for BRCA-mutation carriers: attitudes of Israeli healthcare providers before and after a brief educational intervention.
Perri T; Farhadian Y; Friedman E; Korach J
Menopause; 2020 Jan; 27(1):82-87. PubMed ID: 31688415
[TBL] [Abstract][Full Text] [Related]
6. The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies.
Hickey I; Jha S; Wyld L
Gynecol Oncol; 2021 Mar; 160(3):763-770. PubMed ID: 33317909
[TBL] [Abstract][Full Text] [Related]
7. What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
Hickey M; Moss KM; Brand A; Wrede CD; Domchek SM; Meiser B; Mishra GD; Joffe H
Gynecol Oncol; 2021 May; 161(2):527-534. PubMed ID: 33583580
[TBL] [Abstract][Full Text] [Related]
8. Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Gasparri ML; Taghavi K; Fiacco E; Zuber V; Di Micco R; Gazzetta G; Valentini A; Mueller MD; Papadia A; Gentilini OD
Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31362334
[TBL] [Abstract][Full Text] [Related]
9. Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.
Crosbie EJ; Flaum N; Harkness EF; Clayton RD; Holland C; Martin-Hirsch P; Wood N; Keating P; Woodward ER; Lalloo F; Donnai P; Edmondson RJ; Evans DG
Int J Cancer; 2021 Mar; 148(5):1155-1163. PubMed ID: 33152107
[TBL] [Abstract][Full Text] [Related]
10. A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
Islam RM; Davis SR; Bell RJ; Tejada-Berges T; Wrede CD; Domchek SM; Meiser B; Kirk J; Krejany EO; Hickey M
Menopause; 2021 Mar; 28(7):748-755. PubMed ID: 33739311
[TBL] [Abstract][Full Text] [Related]
11. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.
De Felice F; Marchetti C; Boccia SM; Romito A; Sassu CM; Porpora MG; Muzii L; Tombolini V; Benedetti Panici P
Cancer Treat Rev; 2017 Dec; 61():1-5. PubMed ID: 29028552
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Salpingo-oophorectomy and Breast Cancer Risk for
Conduit C; Milne RL; Friedlander ML; Phillips KA
Cancer Prev Res (Phila); 2021 Nov; 14(11):983-994. PubMed ID: 34348913
[TBL] [Abstract][Full Text] [Related]
13. Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study).
Jiang H; Robinson DL; Lee PVS; Krejany EO; Yates CJ; Hickey M; Wark JD
Osteoporos Int; 2021 Jan; 32(1):101-112. PubMed ID: 32856124
[TBL] [Abstract][Full Text] [Related]
14. Distinctive psychological and social experiences of women choosing prophylactic oophorectomy for cancer prevention.
Meadows R; Padamsee TJ; Paskett ED
Health Care Women Int; 2018 May; 39(5):595-616. PubMed ID: 29319429
[TBL] [Abstract][Full Text] [Related]
15. What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
Hickey M; Moss KM; Mishra GD; Krejany EO; Domchek SM; Wark JD; Trainer A; Wild RA
Gynecol Oncol; 2021 Jul; 162(1):88-96. PubMed ID: 33972087
[TBL] [Abstract][Full Text] [Related]
16. The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
Kershaw V; Hickey I; Wyld L; Jha S
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():7-17. PubMed ID: 34416580
[TBL] [Abstract][Full Text] [Related]
17. BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
Kwon JS; Tinker AV; Hanley GE; Pansegrau G; Sun S; Carey MS; Schrader I
Gynecol Oncol; 2019 Mar; 152(3):459-464. PubMed ID: 30876489
[TBL] [Abstract][Full Text] [Related]
18. Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.
Stjepanovic N; Villacampa G; Nead KT; Torres-Esquius S; Melis GG; Nathanson KL; Teule A; Brunet J; Y Cajal TR; Llort G; Dienstmann R; Rue M; Domchek SM; Balmaña J
Eur J Cancer; 2020 Jun; 132():53-60. PubMed ID: 32325420
[TBL] [Abstract][Full Text] [Related]
19. Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
Arts-de Jong M; Harmsen MG; Hoogerbrugge N; Massuger LF; Hermens RP; de Hullu JA
Gynecol Oncol; 2015 Feb; 136(2):305-10. PubMed ID: 25560807
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.
Berek JS; Chalas E; Edelson M; Moore DH; Burke WM; Cliby WA; Berchuck A;
Obstet Gynecol; 2010 Sep; 116(3):733-743. PubMed ID: 20733460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
